Home' Australian Pharmacist : Australian Pharmacist January 2017 Contents Australian Pharmacist January 2017 I ©Pharmaceutical Society of Australia Ltd.
GC2018 call for
More than 6,600 athletes and team officials from 70 Commonwealth
nations and territories will gather on the Gold Coast from 4–15
April 2018 to share in the excitement of the 2018 Gold Coast
Commonwealth Games (GC2018), and the organisers need
pharmacists and other healthcare professionals for the medical team.
GC2018 will be the largest event to be staged in Australia this decade, putting
the Gold Coast and Queensland on the world sporting stage. It will feature
the largest integrated sports program in Commonwealth Games history,
comprising 18 sports and seven para-sports.
A team of medical and health professionals is required to deliver safe,
appropriate healthcare for athletes, officials, workers and spectators
throughout the Games period.
GC2018 Pharmacy working group member Debbie Rigby FPS told Australian
Pharmacist that she had been privileged to volunteer as a pharmacist at the
Melbourne Commonwealth Games in 2006.
‘ Working at the Polyclinic pharmacy at the Athlete’s Village, I worked
closely with other healthcare professionals to provide the best possible
pharmaceutical care – it was an excellent example of what you can achieve
with integrated, multidisciplinary care.
‘For me, it was a great opportunity to learn more about medication use and
anti-doping in sports and to increase my knowledge and skills. I took away
so much more from the experience than I ever imagined – if you have the
opportunity to be involved, I would say go for it. It will be an experience and
an opportunity that you will never regret.
The GC2018 organisers are encouraging medical and healthcare professionals,
including administrative and team support officers, to volunteer their skills
to be part of Queensland’s biggest ever sporting event. The Commonwealth
Games will provide a wide range of opportunities to build networks and
develop sports and emergency medicine skills.
They have invited pharmacists to join the team by pre-registering their
interest as a medical volunteer at: www.gc2018.com/take-part/volunteering.
Additional information is available at: email@example.com.
FACE-TO-FACE SUNDAY LEARNING SEMINAR
To enhance the learning experience
and maximise the return for attending
face-to-face CPD sessions, PSA is introducing
a new model of Sunday Learning Seminar
in Victoria. This involves lectures with a
high level of interaction from medical and
pharmacy specialists on the subject matter,
followed by a series of small group hands on
sessions focusing on practical tips and tools.
The first Sunday Learning Seminar in
Victoria, on 12 February at Parkville, is on
Rheumatology. Participants will attend a
number of lectures covering updates and
controversies, and clinical pharmacology
in Rheumatology, followed by three
breakout sessions on the Psychology of pain,
the Victorian Osteoarthritis model of care,
and Pharmacists improving outcomes in
This is an enjoyable and relevant learning
experience that offers clinical knowledge
together with practical skills that will
support and grow your practice.
u For details and registration visit the PSA
website: www.psa.org.au or contact
IBUPROFEN MAY REDUCE LUNG
Regular use of ibuprofen may lower the risk of lung
cancer among those with a history of cigarette
smoking, according to research presented at the
IASLC 17th World Conference on Lung Cancer
(WCLC) in Vienna, Austria last month.
It has been established that chronic inflammation
appears to increase the risk of lung cancer, and
medicines that reduce inflammation have been
shown to reduce this risk. However, few prospective
studies have examined associations between lung
cancer and non-steroidal anti-inflammatory drugs.
To test whether a common NSAID could reduce
the risk of lung cancer, Dr Marisa Bittoni and
her colleagues from the Ohio State University
in Columbus, Ohio, examined data from 10,735
participants in the Third National Health and
Nutrition Examination Survey, or NHANES III.
Baseline data on smoking, NSAIDs and other lifestyle
variables were collected for participants starting in
1988–94, and cause-specific mortality status was
ascertained through probabilistic record matching
using the National Death Index through 2006.
Cox proportional hazards regression models were
used to estimate hazard ratios (HRs) to quantify
associations between NSAID use and lung cancer
death, with adjustment for current smoking and
Over the 18 years of follow-up, 269 individuals died
from lung cancer, of whom 252 (93.6%) reported a
history of cigarette smoking. Since all but 17 of the
269 fatal lung cancer cases occurred among current
or former smokers, estimates of NSAID effects were
ascertained from a sub-cohort of 5,882 individuals
who reported a history of past or current cigarette
Links Archive Australian Pharmacist December2016 Navigation Previous Page Next Page